Valuation Metrics Show Encouraging Shift
At the heart of the valuation improvement lies the company’s price-to-earnings (P/E) ratio, which currently stands at 21.15. This figure is significantly lower than many of its peers in the commodity chemicals industry, where P/E ratios often exceed 50, such as Stallion India at 56.14 and Sanstar Chemicals at 64.47. The more moderate P/E ratio suggests that Shree Hari Chemicals Export Ltd is trading at a relatively reasonable multiple of its earnings, enhancing its appeal to value-conscious investors.
Similarly, the price-to-book value (P/BV) ratio of 1.97 remains modest compared to sector heavyweights, indicating that the stock is not excessively priced relative to its net asset value. This contrasts with some peers like Oriental Aromatics, which trades at a P/BV multiple well above 20, reflecting a stretched valuation.
Enterprise Value Multiples Provide Additional Insight
Enterprise value to EBITDA (EV/EBITDA) is another key metric where Shree Hari Chemicals Export Ltd demonstrates relative attractiveness. At 17.10, it is considerably lower than the likes of Sanstar Chemicals (55.24) and Titan Biotech (45.05), suggesting that the company’s operating profitability is valued more reasonably by the market. The EV to EBIT ratio of 26.58, while higher than some peers, remains within a range that does not signal overvaluation.
These valuation multiples collectively underpin the recent upgrade in the company’s valuation grade from very attractive to attractive, a move that reflects improved investor sentiment and a more favourable risk-reward profile.
Comparative Industry Context
When benchmarked against its industry peers, Shree Hari Chemicals Export Ltd’s valuation stands out for its relative moderation. Several competitors are classified as very expensive, including Indo Borax & Chemicals and I G Petrochemicals, with P/E ratios soaring above 30 and even 600 in the case of I G Petrochemicals. This disparity highlights the potential value embedded in Shree Hari Chemicals Export Ltd’s shares, especially for investors seeking exposure to the commodity chemicals sector without the premium valuations.
Moreover, the company’s PEG ratio is reported as 0.00, which may indicate either a lack of meaningful earnings growth expectations or data unavailability. This contrasts with peers like Titan Biotech, which has a PEG of 1.50, suggesting that growth expectations are factored into their higher valuations.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
Financial Performance and Returns Contextualise Valuation
Shree Hari Chemicals Export Ltd’s return profile over various time horizons further supports the valuation upgrade. The stock has delivered a remarkable 201.6% return over three years, vastly outperforming the Sensex’s 16.84% gain over the same period. Even over five years, the stock’s 94.36% return dwarfs the Sensex’s 45.25%, underscoring the company’s ability to generate shareholder value despite its micro-cap status.
Year-to-date, the stock has gained 3.85%, while the Sensex has declined by 9.43%, reflecting resilience amid broader market volatility. However, the one-year return of 2.29% remains modest, indicating some recent consolidation or sector headwinds.
Profitability Metrics and Operational Efficiency
On the profitability front, Shree Hari Chemicals Export Ltd reports a return on capital employed (ROCE) of 6.07% and a return on equity (ROE) of 9.30%. While these figures are not stellar, they are consistent with the company’s valuation grade of Hold and suggest moderate operational efficiency. Investors should note that these returns are below the levels typically seen in more aggressively valued peers, which may justify the current valuation discount.
The absence of a dividend yield further emphasises the company’s focus on reinvestment or growth rather than immediate shareholder payouts, a factor that may influence income-focused investors’ decisions.
Price Movement and Market Capitalisation
Currently priced at ₹136.05, Shree Hari Chemicals Export Ltd’s stock has experienced a slight decline of 1.02% on the day, with intraday trading ranging between ₹130.55 and ₹138.00. The stock remains comfortably above its 52-week low of ₹87.65 but has yet to reclaim its 52-week high of ₹146.70, indicating some room for upside if market conditions improve.
As a micro-cap entity, the company’s market capitalisation remains modest, which can contribute to higher volatility but also presents opportunities for investors willing to navigate smaller-cap dynamics.
Shree Hari Chemicals Export Ltd or something better? Our SwitchER feature analyzes this micro-cap Commodity Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Outlook and Investment Considerations
The recent upgrade in Shree Hari Chemicals Export Ltd’s valuation grade from very attractive to attractive, coupled with the Mojo Grade improvement from Sell to Hold on 13 July 2026, signals a cautious but more optimistic stance from analysts. The company’s valuation metrics suggest it is reasonably priced relative to its earnings and book value, especially when contrasted with its more expensive peers.
However, investors should weigh the moderate profitability metrics and the absence of dividend yield against the stock’s strong historical returns and valuation appeal. The micro-cap nature of the company also implies a higher risk profile, including liquidity constraints and potential volatility.
In the context of the broader commodity chemicals sector, where many stocks trade at stretched valuations, Shree Hari Chemicals Export Ltd offers a comparatively attractive entry point for investors seeking exposure to this space without paying a premium. The stock’s recent performance relative to the Sensex further reinforces its potential as a resilient investment option.
Overall, the valuation improvement and rating upgrade reflect a more balanced risk-reward profile, making Shree Hari Chemicals Export Ltd a stock to watch for investors with a medium to long-term horizon who are comfortable with micro-cap dynamics.
Summary
Shree Hari Chemicals Export Ltd’s shift in valuation parameters, particularly its P/E and P/BV ratios, marks a significant development in its investment narrative. Trading at a P/E of 21.15 and a P/BV of 1.97, the stock is attractively valued compared to its peers, many of which are classified as expensive or very expensive. The company’s moderate profitability and strong historical returns complement this valuation story, justifying the recent upgrade to a Hold rating and an attractive valuation grade. While risks remain inherent in its micro-cap status and sector volatility, the stock presents a compelling case for investors seeking value in the commodity chemicals industry.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
